» Articles » PMID: 38228469

Impaired Plasma Glucose Clearance is a Key Determinant of Fasting Hyperglycemia in People with Obesity

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to evaluate the relative importance of the basal rate of glucose appearance (Ra) in the circulation and the basal rate of plasma glucose clearance in determining fasting plasma glucose concentration in people with obesity and different fasting glycemic statuses.

Methods: The authors evaluated basal glucose kinetics in 33 lean people with normal fasting glucose (<100 mg/dL; Lean < 100 group) and 206 people with obesity and normal fasting glucose (Ob < 100 group, n = 118), impaired fasting glucose (100-125 mg/dL; Ob 100-125 group, n = 66), or fasting glucose diagnostic of diabetes (≥126 mg/dL; Ob ≥ 126 group, n = 22).

Results: Although there was a large (up to three-fold) range in glucose Ra within each group, the ranges in glucose concentration in the Lean < 100, Ob < 100, and Ob 100-125 groups were small because of a close relationship between glucose Ra and clearance rate. However, the glucose clearance rate at any Ra value was lower in the hyperglycemic than the normoglycemic groups. In the Ob ≥ 126 group, plasma glucose concentration was primarily determined by glucose Ra, because glucose clearance was markedly attenuated.

Conclusions: Fasting hyperglycemia in people with obesity represents a disruption of the precisely regulated integration of glucose production and clearance rates.

Citing Articles

Boosting Therapeutic Effect of Turmeric, Coffee, and Chili Extracts Through Experimental Design and Encapsulation as Nanostructured Lipid Carriers for Novel Heath Supplements.

Tipduangta P, Saokham P, Jiaranaikulwanitch J, Okonogi S, Ampasavate C, Kiattisin K Plants (Basel). 2025; 14(2).

PMID: 39861589 PMC: 11768308. DOI: 10.3390/plants14020236.

References
1.
Honka H, Makinen J, Hannukainen J, Tarkia M, Oikonen V, Teras M . Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia. 2013; 56(4):893-900. DOI: 10.1007/s00125-012-2825-5. View

2.
Ferrannini E . A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture. Diabetes. 2021; 70(2):338-346. PMC: 7881861. DOI: 10.2337/dbi20-0028. View

3.
Yoshino M, Kayser B, Yoshino J, Stein R, Reeds D, Eagon J . Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes. N Engl J Med. 2020; 383(8):721-732. PMC: 7456610. DOI: 10.1056/NEJMoa2003697. View

4.
Basu A, Basu R, Shah P, Vella A, Johnson C, Nair K . Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000; 49(2):272-83. DOI: 10.2337/diabetes.49.2.272. View

5.
Smith G, Polidori D, Yoshino M, Kearney M, Patterson B, Mittendorfer B . Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. J Clin Invest. 2020; 130(6):3305-3314. PMC: 7260030. DOI: 10.1172/JCI136756. View